Cleared Traditional

K250160 - ANKYRAS (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K250160 · Mentice Spain S.L. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2025
Decision
105d
Days
Class 2
Risk

K250160 is an FDA 510(k) clearance for the ANKYRAS. Classified as Software For Visualization Of Vascular Anatomy And Intravascular Devices (product code PZO), Class II - Special Controls.

Submitted by Mentice Spain S.L. (Barcelona, ES). The FDA issued a Cleared decision on May 6, 2025 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 892.2050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Mentice Spain S.L. devices

Submission Details

510(k) Number K250160 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 2025
Decision Date May 06, 2025
Days to Decision 105 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 148d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PZO Software For Visualization Of Vascular Anatomy And Intravascular Devices
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition Visualization And Measurement Of Blood Vessels And Intravascular Devices For Preoperational Planning.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - PZO Software For Visualization Of Vascular Anatomy And Intravascular Devices

All 9
Devices cleared under the same product code (PZO) and FDA review panel - the closest regulatory comparables to K250160.
Sim&Size
K253122 · Sim&Cure · Dec 2025
Sim&Size
K242124 · Sim&Cure · Dec 2024
Ankyras
K230006 · Mentice Spain S.L. · Dec 2023
Sim&Size
K222664 · Sim&Cure · Jan 2023
AneuGuide
K213838 · ArteryFlow Technology Co., Ltd. · Jun 2022
Sim&Size
K212373 · Sim&Cure · Jan 2022